FMC Corporation 10-Q Summary: Quarter Ended September 30, 2002
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2002, and the nine-month period ended on that date. FMC Corporation operates as a chemical company following the spin-off of its machinery business, FMC Technologies, Inc., in December 2001. The company is organized into three primary segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The financial statements are unaudited but have been reviewed by independent accountants.
Key Financial Metrics
| Metric (in millions) | 3 Months Ended 9/30/02 | 9 Months Ended 9/30/02 | 9 Months Ended 9/30/01 |
|---|---|---|---|
| Revenue | $476.6 | $1,393.2 | $1,453.2 |
| Net Income | $28.2 | $56.4 | $(305.0) |
| Diluted EPS | $0.79 | $1.66 | $(9.83) |
| Operating Income | $51.4 | $117.0 | $(367.8) |
| Cash from Operations | N/A | $76.5 | $(24.7) |
| Total Debt | $889.9 | $889.9 | $923.5 (Year End 2001) |
| Cash & Equivalents | $37.3 | $37.3 | $23.4 (Year End 2001) |
Margins: Operating margin for the nine months ended September 30, 2002, was approximately 8.4% ($117.0M / $1,393.2M), a significant improvement from the negative margin in the prior year due to the absence of massive impairment charges.
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $56.4 million for the nine months of 2002, compared to a net loss of $305.0 million in the same period of 2001. This reversal is primarily driven by the absence of $323.1 million in asset impairments and $184.5 million in restructuring charges recorded in 2001.
- Revenue Decline: Revenue decreased 4.1% year-over-year for the nine-month period. This was attributed to lower phosphate sales (loss of a major European customer), lower alkali sales, and a strategic reduction in sulfentrazone herbicide sales.
- Restructuring Costs: Restructuring and other charges dropped significantly to $14.4 million in the first nine months of 2002, compared to $184.5 million in 2001. The 2001 charges were heavily influenced by the shutdown of the Pocatello, Idaho facility and the spin-off of Technologies.
- Asset Impairments: No asset impairments were recorded in 2002, contrasting with $323.1 million in 2001 related to the phosphorus business and lithium operations in Argentina.
Guidance, Outlook, and Risks
Refinancing: Subsequent to the quarter-end (October 21, 2002), FMC completed a major refinancing. This included issuing $355.0 million in 10.25% Senior Secured Notes due 2009 and establishing a new $500.0 million credit facility. Proceeds were used to repay maturing debt, terminate the old revolving credit facility, and collateralize letters of credit.
Outlook:
- Agricultural Products: Management expects improvement in the fourth quarter due to cost savings and a shift to higher-value insecticides.
- Specialty Chemicals: Continued growth is expected, though a large one-time lithium sale in 2001 will not repeat.
- Industrial Chemicals: No significant market improvements are expected until late 2003. Fourth-quarter earnings are projected to be flat due to ongoing cost-saving efforts and the mothballing of capacity at the Spring Hill facility.
Risks and Contingencies:
- Environmental Obligations: Reserves total $195.4 million (net of recoveries). Management estimates reasonably possible contingent losses could exceed accrued amounts by up to $70.0 million.
- Astaris Joint Venture: FMC is committed to making equity contributions to Astaris to cover half of any earnings shortfall. Contributions of $27.8 million were made in the first nine months of 2002, with full-year expectations similar to 2001 levels.
- Legal Proceedings: The company faces asbestos-related litigation, though management believes claims are without merit and the outcome will not be material.
Investor Verification Checklist
- Refinancing Terms: Verify the impact of the new 10.25% Senior Secured Notes and the $500M credit facility on future interest expense and liquidity covenants.
- Pocatello Shutdown Costs: Confirm the remaining $53.0 million reserve for Pocatello shutdown and remediation and the timeline for spending through 2007.
- Astaris Contributions: Monitor the performance of the Astaris joint venture to assess the risk of additional equity contributions beyond the estimated $31.3 million for 2002.
- Environmental Reserves: Review the adequacy of the $195.4 million environmental reserve against the potential $70.0 million in additional contingent losses.
- Segment Mix: Validate the strategic shift in Agricultural Products from soybeans (sulfentrazone) to higher-value crops and its impact on long-term revenue stability.